ArticleThe Journal of clinical investigation2024

Neutralizing activity of anti-SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants.

Lorenza Bellusci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.